Erythropoietin, the FDA, and oncology. [electronic resource]
Producer: 20070621Description: 2448-51 p. digitalISSN:- 1533-4406
- Advisory Committees
- Anemia -- chemically induced
- Darbepoetin alfa
- Epoetin Alfa
- Erythropoietin -- adverse effects
- Health Expenditures -- trends
- Hematinics -- adverse effects
- Humans
- Insurance Coverage -- legislation & jurisprudence
- Medicare -- economics
- Neoplasms -- complications
- Recombinant Proteins
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.